DalsnaFinance › IPOs › Unicycive Therapeutics › IPO
Unicycive Therapeutics, Inc. completed its initial public offering on NASDAQ on July 13, 2021, pricing at $5.00 a share.
| Ticker | UNCY |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 13, 2021 |
| Offering price | $5.00 |
| Shares offered | 5,000,000 |
| Total raised | $25M |
Unicycive Therapeutics, Inc. sold 5,000,000 shares at $5.00 each on NASDAQ. Multiplied out, that is $25 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $25 million total recorded for the deal.
Unicycive Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Unicycive Therapeutics, Inc.. This page is general information, not investment advice.